News
Unlike injectable peptides, which bypass the digestive system, oral BPC-157 depends on formulation integrity and absorption ...
1h
Everyday Health on MSNZebound Beats Wegovy for Weight Loss in First Head-to-Head TrialIn a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...
Dark chocolate biscuits could aid weight loss, say scientists. Antioxidants in cocoa-rich dark chocolate may trigger the gut ...
Whether it's drawing blood or administering medication, needles scare many people, and not everyone can imagine doing it ...
Cash, cash equivalents and short-term investments were $83.1 million as of March 31, 2025, compared to $125.7 million as of December 31, 2024. Adverum expects its cash, cash equivalents and short-term ...
Recent research shows combining weight loss with blood sugar control is even more effective for reducing health risks ...
Doctors generally have an easier time diagnosing type 1 diabetes in kids, who present with classic symptoms of excessive thirst, excessive urination, and weight loss. “Children often have a really ...
It seems Novo Nordisk is leaving no stone unturned as it builds a pipeline of drug candidates for obesity and cardiometabolic ...
Mounjaro. Ozempic. Wegovy. Zepbound. All these are brand names linked in some way to diabetes and weight loss-or, as the ...
Ascendis Pharma A/S (Nasdaq: ASND) today announced new data showing improvements in growth and bone morphometry from Week 52 of its pivotal ApproaCH ...
5h
AZoLifeSciences on MSNLight-Based 3D Printing for Precise Cellular Organization in Tissue EngineeringThe Terasaki Institute's light-based 3D printing method advances tissue engineering, enabling tailored microgels for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results